Childhood pemphigus vulgaris successfully treated with rituximab

Posté le September 25, 2012 par Cristo Rey Intern

Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. Cependant, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an…

Tagués avec : Autoimmune bullous diseases, childhood pemphigus vulgaris, rituximab
Publié dans Dans le monde entier, Actualités et informations

Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases

Posté le June 4, 2012 par Cristo Rey Intern

Rituximab has been reported to be effective in various small case series of patients with severe and/or refractory pemphigus. Cependant, no systematic evaluation is available to corroborate this observation. The aim of this study was to systematically determine efficacy and…

Tagués avec : data, registry, rituximab
Publié dans Dans le monde entier, Registre de patients de P - P, Recherche axée sur le registre

Archives du site

Childhood pemphigus vulgaris successfully treated with rituximab

Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases